MX9803662A - Oligopeptidos novedosos, preparacion y uso de estos. - Google Patents

Oligopeptidos novedosos, preparacion y uso de estos.

Info

Publication number
MX9803662A
MX9803662A MX9803662A MX9803662A MX9803662A MX 9803662 A MX9803662 A MX 9803662A MX 9803662 A MX9803662 A MX 9803662A MX 9803662 A MX9803662 A MX 9803662A MX 9803662 A MX9803662 A MX 9803662A
Authority
MX
Mexico
Prior art keywords
dolastatin
peptide derivatives
novel
formula
preparation
Prior art date
Application number
MX9803662A
Other languages
English (en)
Inventor
Andreas Kling
Bernd Janssen
Wilhelm Amberg
Andreas Haupt
Kurt Ritter
Ernst Buschmann
Harald Bernard
Stefan Muller
Thomas Zierke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of MX9803662A publication Critical patent/MX9803662A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion se refiere a los péptidos novedosos de la formula: A-B-D-E-F-L, en donde A, B, D, E, F y L tienen los significados mencionados en la especificacion, y su preparacion. Los compuestos novedosos son adecuados para controlar enfermedades.
MX9803662A 1995-11-09 1998-05-08 Oligopeptidos novedosos, preparacion y uso de estos. MX9803662A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/554,897 US5807984A (en) 1995-11-09 1995-11-09 Oligopeptides, the preparation and use thereof

Publications (1)

Publication Number Publication Date
MX9803662A true MX9803662A (es) 1998-09-30

Family

ID=24215159

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9803662A MX9803662A (es) 1995-11-09 1998-05-08 Oligopeptidos novedosos, preparacion y uso de estos.

Country Status (12)

Country Link
US (1) US5807984A (es)
EP (1) EP0859786A1 (es)
JP (1) JPH11515032A (es)
KR (1) KR19990067460A (es)
AU (1) AU729333B2 (es)
BR (1) BR9611383A (es)
CZ (1) CZ139198A3 (es)
HU (1) HUP9900089A3 (es)
MX (1) MX9803662A (es)
NO (1) NO982100D0 (es)
WO (1) WO1997017364A1 (es)
ZA (1) ZA969402B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010009901A1 (en) 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US5965537A (en) * 1997-03-10 1999-10-12 Basf Aktiengesellschaft Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
US6143721A (en) * 1997-07-18 2000-11-07 Basf Aktiengesellschaft Dolastatin 15 derivatives
ATE293638T1 (de) * 1997-09-24 2005-05-15 Univ Arizona Synthetische antineoplastische wirkstoffe abgeleitet von dolastatin 15 sowie verfahren zu ihrer herstellung
US6686445B1 (en) 1997-09-24 2004-02-03 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
FR2774989B1 (fr) * 1998-02-18 2000-03-17 Adir Nouveaux cytotoxiques derives de l'oestradiol
US5985837A (en) * 1998-07-08 1999-11-16 Basf Aktiengesellschaft Dolastatin 15 derivatives
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
MX2024002571A (es) 2021-09-03 2024-03-20 Toray Industries Composicion farmaceutica para tratamiento y/o prevencion de cancer.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
DK0934950T3 (da) * 1991-08-09 2002-07-29 Teikoku Hormone Mfg Co Ltd Tetrapeptidderivat
CZ292612B6 (cs) * 1992-05-20 2003-11-12 Abbott Gmbh & Co. Kg Peptid s protirakovinnou aktivitou, jeho použití a farmaceutický prostředek s obsahem takového peptidu
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
HUT72067A (en) * 1992-12-16 1996-03-28 Basf Ag Dolostatin analog
US5530097A (en) * 1994-08-01 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory peptide amides
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters

Also Published As

Publication number Publication date
BR9611383A (pt) 1999-01-26
WO1997017364A1 (en) 1997-05-15
KR19990067460A (ko) 1999-08-16
NO982100L (no) 1998-05-08
ZA969402B (en) 1998-05-08
AU729333B2 (en) 2001-02-01
HUP9900089A2 (hu) 1999-05-28
US5807984A (en) 1998-09-15
JPH11515032A (ja) 1999-12-21
AU7495796A (en) 1997-05-29
EP0859786A1 (en) 1998-08-26
CZ139198A3 (cs) 1998-09-16
NO982100D0 (no) 1998-05-08
HUP9900089A3 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
MY132115A (en) Novel thrombin inhibitors
IL128231A0 (en) Novel benzamidines
WO1996040757A3 (en) Lhrh antagonist peptides
MY124487A (en) Dolastatin derivatives, their preparation and use
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
MY132820A (en) Novel thrombin inhibitors
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU7068896A (en) Protein composition derived from sesame seed and use thereof
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
DE59700356D1 (en) Kombinationspräparat, enthaltend 5-methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid und n-(4-trifluormethylphenyl)-2-cyan-3-hydroxycrotonsäureamid
MX9803662A (es) Oligopeptidos novedosos, preparacion y uso de estos.
AU2467395A (en) Novel ophthalmologic uses of protein c
AU7000896A (en) Novel peptide compounds and medicinal compositions thereof
AU6530496A (en) New protein HMW human MP52
GR3019372T3 (en) Peptide antagonists of bradykinin
IL122817A0 (en) MP 52 ARG protein
AU4483696A (en) Novel peptides, their production and use
AU4865796A (en) Ophthalmic compositions including peptides and peptide derivatives and methods for using same
AU4594696A (en) Human stem cell antigen 2
MY114327A (en) Novel peptides, the preparation and use thereof
AU7011896A (en) Human hypothalmic ("hr") receptor polypeptide compositions, methods and uses thereof
AU6456096A (en) Lysine 1689 factor viii:c polypeptide analogs
AU2659900A (en) Human interleukin 10 mutant proteins
AU3361093A (en) Use of muramyl peptides for enhancing animal production
AU674371B2 (en) New triazolopyrimidones, their preparation and their use